Grace Therapeutics Insider Opaleye Management Inc. Buys $18.5K of Stock
Opaleye Management Inc. bought 10,328 shares of Grace Therapeutics, Inc. at $1.79 a share, worth $18.5K in total on Nov 3, 2026. Shares held after the trade: 3,046,739 (+0.3%).
Grace Therapeutics Insider Opaleye Management Inc. Buys $159K of Stock
Opaleye Management Inc. bought 87,801 shares of Grace Therapeutics, Inc. at $1.77 to $1.93 a share (average $1.81) in 2 transactions, worth $159K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,036,411 (+2.2%).
Grace Therapeutics Insider Opaleye Management Inc. Buys $136K of Stock
Opaleye Management Inc. bought 71,065 shares of Grace Therapeutics, Inc. at $1.89 to $1.95 a share (average $1.92) in 3 transactions, worth $136K in total between Oct 14, 2026 and Oct 16, 2026. Shares held after the trade: 2,944,354 (+1.2%).
Grace Therapeutics Insider Opaleye Management Inc. Buys $25.5K of Stock
Opaleye Management Inc. bought 12,555 shares of Grace Therapeutics, Inc. at $2.02 to $2.04 a share (average $2.03) in 2 transactions, worth $25.5K in total between Oct 9, 2026 and Oct 12, 2026. Shares held after the trade: 2,873,289 (+0.3%).
Grace Therapeutics Insider Opaleye Management Inc. Buys $120K of Stock
Opaleye Management Inc. bought 58,796 shares of Grace Therapeutics, Inc. at $2.04 to $2.07 a share (average $2.05) in 2 transactions, worth $120K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 2,856,963 (+0.7%).
Grace Therapeutics Insider Opaleye Management Inc. Buys $16.4K of Stock
Opaleye Management Inc. bought 7,849 shares of Grace Therapeutics, Inc. at $2.09 a share, worth $16.4K in total on Sep 29, 2026. Shares held after the trade: 2,798,167 (+0.3%).